713 related articles for article (PubMed ID: 26582515)
1. Innate Immune Signaling Activated by MDR Bacteria in the Airway.
Parker D; Ahn D; Cohen T; Prince A
Physiol Rev; 2016 Jan; 96(1):19-53. PubMed ID: 26582515
[TBL] [Abstract][Full Text] [Related]
2. Pseudomonas aeruginosa and Klebsiella pneumoniae Adaptation to Innate Immune Clearance Mechanisms in the Lung.
Riquelme SA; Ahn D; Prince A
J Innate Immun; 2018; 10(5-6):442-454. PubMed ID: 29617698
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.
Sader HS; Castanheira M; Flamm RK
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28069649
[TBL] [Abstract][Full Text] [Related]
4. Update on the main MDR pathogens: prevalence and treatment options.
Esposito S; De Simone G
Infez Med; 2017 Dec; 25(4):301-310. PubMed ID: 29286008
[TBL] [Abstract][Full Text] [Related]
5. Toll/IL-1R domain-containing adaptor protein (TIRAP) is a critical mediator of antibacterial defense in the lung against Klebsiella pneumoniae but not Pseudomonas aeruginosa.
Jeyaseelan S; Young SK; Yamamoto M; Arndt PG; Akira S; Kolls JK; Worthen GS
J Immunol; 2006 Jul; 177(1):538-47. PubMed ID: 16785551
[TBL] [Abstract][Full Text] [Related]
6. Acid Aspiration Impairs Antibacterial Properties of Liver Macrophages.
Langelage M; Better J; Wetstein M; Selvakumar B; Malainou C; Kimmig L; Arneth B; Köhler K; Herden C; Herold S; Matt U
Am J Respir Cell Mol Biol; 2021 May; 64(5):641-643. PubMed ID: 33929292
[No Abstract] [Full Text] [Related]
7. Etiological factors causing lower respiratory tract infections isolated from hospitalized patients.
Guzek A; Rybicki Z; Korzeniewski K; Mackiewicz K; Saks E; Chciałowski A; Zwolińska E
Adv Exp Med Biol; 2015; 835():37-44. PubMed ID: 25310945
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations of pneumonia according to the causative organism in patients in the intensive care unit.
Lee JK; Lee J; Park YS; Lee CH; Yim JJ; Yoo CG; Kim YW; Han SK; Lee SM
Korean J Intern Med; 2015 Nov; 30(6):829-36. PubMed ID: 26552458
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of antimicrobial susceptibility among bacterial isolates from intensive care unit patients of a tertiary-care university hospital in Iran: 2006-2009.
Mohammadtaheri Z; Pourpaki M; Mohammadi F; Namdar R; Masjedi MR
Chemotherapy; 2010; 56(6):478-84. PubMed ID: 21099220
[TBL] [Abstract][Full Text] [Related]
10. Vaccination induces rapid protection against bacterial pneumonia via training alveolar macrophage in mice.
Gu H; Zeng X; Peng L; Xiang C; Zhou Y; Zhang X; Zhang J; Wang N; Guo G; Li Y; Liu K; Gu J; Zeng H; Zhuang Y; Li H; Zhang J; Zhang W; Zou Q; Shi Y
Elife; 2021 Sep; 10():. PubMed ID: 34544549
[TBL] [Abstract][Full Text] [Related]
11. [Distribution of bacteria and analysis of their sensibility to antibiotics in patients with hospital-acquired pneumonia].
Cheng WC; Xiang XD; Chen P; Zan JN
Hunan Yi Ke Da Xue Xue Bao; 2000 Dec; 25(6):567-9. PubMed ID: 12516407
[TBL] [Abstract][Full Text] [Related]
12. The Neutrophilic Response to Pseudomonas Damages the Airway Barrier, Promoting Infection by Klebsiella pneumoniae.
Jones-Nelson O; Hilliard JJ; DiGiandomenico A; Warrener P; Alfaro A; Cheng L; Stover CK; Cohen TS; Sellman BR
Am J Respir Cell Mol Biol; 2018 Dec; 59(6):745-756. PubMed ID: 30109945
[TBL] [Abstract][Full Text] [Related]
13. [Bacterial etiology of nosocomial pneumonia and antimicrobial resistance in patients with and without antimicrobial treatment].
Weyland B; Perazzi B; García S; Rodríguez C; Vay C; Famiglietti A
Rev Argent Microbiol; 2011; 43(1):18-23. PubMed ID: 21491061
[TBL] [Abstract][Full Text] [Related]
14. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
[TBL] [Abstract][Full Text] [Related]
16. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
Hamouche E; Sarkis DK
Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
[TBL] [Abstract][Full Text] [Related]
17.
Zhao M; Lepak AJ; Marchillo K; Andes DR
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332063
[TBL] [Abstract][Full Text] [Related]
18. Immunometabolites Drive Bacterial Adaptation to the Airway.
Tomlinson KL; Prince AS; Wong Fok Lung T
Front Immunol; 2021; 12():790574. PubMed ID: 34899759
[No Abstract] [Full Text] [Related]
19. Partially-desulfated heparin improves survival in Pseudomonas pneumonia by enhancing bacterial clearance and ameliorating lung injury.
Sharma L; Wu J; Patel V; Sitapara R; Rao NV; Kennedy TP; Mantell LL
J Immunotoxicol; 2014; 11(3):260-7. PubMed ID: 24099632
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection.
Lou W; Venkataraman S; Zhong G; Ding B; Tan JPK; Xu L; Fan W; Yang YY
Acta Biomater; 2018 Sep; 78():78-88. PubMed ID: 30031912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
